Reported Earlier, Artiva Biotherapeutics Prices Upsized $167M Initial Public Offering Of 13.92M Common Shares At $12/Share
Portfolio Pulse from Benzinga Newsdesk
Artiva Biotherapeutics has priced its upsized $167 million initial public offering (IPO) of 13.92 million common shares at $12 per share. The shares will begin trading on the Nasdaq Global Market under the symbol 'ARTV' on July 19, 2024, with the offering expected to close on July 22, 2024, pending customary closing conditions.
July 19, 2024 | 6:27 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Artiva Biotherapeutics has announced the pricing of its upsized $167 million IPO, with shares set to trade on Nasdaq under the symbol 'ARTV' starting July 19, 2024. The offering is expected to close on July 22, 2024, subject to customary conditions.
The successful pricing and upsizing of Artiva Biotherapeutics' IPO indicates strong investor demand, which is likely to positively impact the stock price when it begins trading. The biotech sector often sees significant interest in new IPOs, especially when they are upsized.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100